NIH published NOT-OD-15-050, which provided guidance on NIH Fiscal Operations for FY 2015 and implements the Consolidated and Further Continuing Appropriatons Act,2015.
The following NIH fiscal policies are instituted for FY 2015:
FY 2015 Funding Levels: Non-competing continuation awardst that have already been made in FY 2015 were generally funded at levels below that indicated on the most recent notice of award (generally up to 90% of previously committed levels – see NOT-OD-15-001). Such reductions may be fully or partially restored, depending on the Institute or Center. Non-competing continuation grants, including those that remaing to be issued, likely will be made within the range between the commitment level indicated on the notice of award and 3% below that level. Out-year commitments for continuation awards in FY 2016 and beyond will remain unchanged. The NIH awarding Institutes/Centers will develop and post their fiscal policies consistent with the overall NIH goals and available FY 2015 funds.
Ruth L. Kirschstein National Research Service Awards (NRSA): Consistent with the 2015 Consolidated and Further Continuing Appropriations Act and with the recommendations of the Advisory Committee to the Director regarding Biomedical Research Workforce, the NIH will increase NRSA stipends by 2% on average. The full range of stipend adjustments for FY 2015 is described in NOT-OD-15-048.
New Investigators: NIH will continue to support new investigators on R01 equivalent awards at success rates comparable to that of established investigators submitting new (Type 1) R01 equivalent applications. Acheivement of comparable success rates should permit the NIH to support new investigators in accordance with the policies established in FY 2009 and subsequent years – see NOT-OD-09-013.
Salary Limits: Section 203 of the 2015 Consolidated and Further Continuing Appropriations Act prohibits payments for salaries under grants and other extramural mechanisms in excess of Executive Level II – see NOT-OD-15-049.
Please see NOT-OD-15-050 for additional information.
